Type I interferons and limitin: a comparison of structures, receptors, and functions

被引:62
作者
Oritani, K
Kincade, PW
Zhang, C
Tomiyama, Y
Matsuzawa, Y
机构
[1] Osaka Univ, Grad Sch Med, Dept Internal Med & Mol Sci, Suita, Osaka 5650871, Japan
[2] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA
基金
日本学术振兴会; 美国国家卫生研究院;
关键词
interferon; limitin; myelosuppression; antitumor; immune defence;
D O I
10.1016/S1359-6101(01)00009-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The type I interferon (IFN) family includes IFN-alpha, IFN-beta, IFN-omega, and IFN-tau. These molecules are clustered according to sequence homologies, use of the same cell surface receptor, and similar functions. IFN-alpha and IFN-beta have a globular structure composed of five a-helices, Their receptors. IFNAR1 and IFNAR2. belong to the class II cytokine receptor family for a-helical cytokines. Information about structure-function relationships between these and other IFNs is being provided by comparative sequence analysis, reference to a prototypic three-dimensional structure, analysis with monoclonal antibodies, construction of hybrid molecules and site directed mutagenesis. While much remains to be done, it should someday be possible to understand differences among IFNs in terms of how they interact with their corresponding receptors. Our recently identified IFN-like molecule, limitin, has weak sequence homology to IFN-alpha, IFN-beta, and IFN-omega and displays its biological functions through the same IFN-alpha/beta receptors. While limitin has antiproliferative, immunomodulatory, and antiviral effects like IFN-alpha and IFN-beta, it is unique in lacking influence on myeloid and erythroid progenitors. Further analysis of this functionally unique cytokine should be informative about complex IFN-receptor interactions. Furthermore. a human homologue or synthetic variant might be superior for clinical applications as an IFN without myelosuppressive properties. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:337 / 348
页数:12
相关论文
共 103 条
[1]   DIFFERENTIAL TYROSINE PHOSPHORYLATION OF THE IFNAR CHAIN OF THE TYPE-I INTERFERON RECEPTOR AND OF AN ASSOCIATED SURFACE PROTEIN IN RESPONSE TO IFN-ALPHA AND IFN-BETA [J].
ABRAMOVICH, C ;
SHULMAN, LM ;
RATOVITSKI, E ;
HARROCH, S ;
TOVEY, M ;
EID, P ;
REVEL, M .
EMBO JOURNAL, 1994, 13 (24) :5871-5877
[2]  
Aman MJ, 1996, EXP HEMATOL, V24, P863
[3]   REGULATION OF CYTOKINE EXPRESSION BY INTERFERON-ALPHA IN HUMAN BONE-MARROW STROMAL CELLS - INHIBITION OF HEMATOPOIETIC GROWTH-FACTORS AND INDUCTION OF INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AMAN, MJ ;
KELLER, U ;
DERIGS, G ;
MOHAMADZADEH, M ;
HUBER, C ;
PESCHEL, C .
BLOOD, 1994, 84 (12) :4142-4150
[4]   SPECIFICITY AND REVERSIBILITY OF INTERFERON GANGLIOSIDE INTERACTION [J].
BESANCON, F ;
ANKEL, H ;
BASU, S .
NATURE, 1976, 259 (5544) :576-578
[5]   Virus-induced transient bone marrow aplasia: Major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus [J].
Binder, D ;
Fehr, J ;
Hengartner, H ;
Zinkernagel, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :517-530
[6]  
BLACKMAN MJ, 1985, IMMUNOLOGY, V56, P451
[7]  
BROXMEYER HE, 1983, J IMMUNOL, V131, P1300
[8]   B cell development and differentiation [J].
Burrows, PD ;
Cooper, MD .
CURRENT OPINION IN IMMUNOLOGY, 1997, 9 (02) :239-244
[9]  
CEBRIAN M, 1987, J IMMUNOL, V138, P484
[10]   LPR AND GLD - SINGLE GENE MODELS OF SYSTEMIC AUTOIMMUNITY AND LYMPHOPROLIFERATIVE DISEASE [J].
COHEN, PL ;
EISENBERG, RA .
ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :243-269